Table 3.
The Overall Survival Rate Between Two Groups (MDT and Non-MDT) Among All Patients, Patients with ccRCC or Non-ccRCC
| Survival rate | Non-MDT Group | MDT Group | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1-year | 2-year | 3-year | 5-year | 8-year | 1-year | 2-year | 3-year | 5-year | 8-year | |
| All | 83.40% | 60.20% | 45.10% | 20.50% | 8.90% | 90.50% | 83.90% | 68.10% | 55.30% | 23.00% |
| ccRCC | 84.70% | 64.90% | 48.50% | 21.10% | 7.40% | 90.90% | 81.60% | 73.00% | 57.30% | 23.90% |
| non-ccRCC | 76.40% | 44.40% | 33.60% | - | - | 89.4% | 84.9% | 56.1% | - | - |
Abbreviations: MDT, Multidisciplinary team; ccRCC, Clear cell renal cell carcinoma.